Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Daiichi Sankyo logo

Daiichi Sankyo on track for edoxaban filing in 2014

Positive phase III data for anticoagulant

- PMLiVE

Meda buys US respiratory firm Acton in $200m deal

Swedish pharma firm gains access to asthma treatment Aerospan

- PMLiVE

FDA investigates safety of Novartis’ MS drug

Agency to determine association between Gilenya and rare brain infection

- PMLiVE

AZ launches breast cancer video portal

Pharma company partners with oncology publisher for new HCP resource

- PMLiVE

Merck KGaA appoints new chief information officer

Promotes the head of its strategy realisation office James Stewart

- PMLiVE

Mapping influencers in healthcare

Harnessing influence is vital for effective healthcare marketing, but robust, reliable methods of understanding its nature and identifying those who have it are needed

- PMLiVE

FDA turns down Otsuka’s kidney disease candidate

Requests additional information for tolvaptan

Bayer symbol

EU nod for Bayer’s Stivarga as Nexavar gets US priority review

Advances pharma company’s ambitions in cancer

Novartis building

NICE backs Novartis’ Jetrea in rare eye condition

Recommends drug be available for NHS use to treat vitreomacular traction

- PMLiVE

ReNeuron wins orphan status for stem cell therapy

ReN003 is being assessed as a treatment for rare eye disorder retinitis pigmentosa

- PMLiVE

Marschall Runge joins Lilly’s board of directors

Will serve on the pharma company's Science and Technology, and Public Policy and Compliance Committees

- PMLiVE

Novartis takes breast cancer campaign to Pinterest

Expands ongoing digital awareness efforts for advanced breast cancer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links